CYTOKINES AS ENDOGENOUS MEDIATORS OF CANCER CACHEXIA
CYTOKINES AS ENDOGENOUS MEDIATORS OF CANCER CACHEXIA
批准号:
3196886
负责人:
LYLE L MOLDAWER
金额:
$12.98万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 1995-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Anorexia, weight loss and cachexia are the most visibly recognizable
symptoms associated with cancer. However, the causes of cancer cachexia
remain unknown. This application proposes that the anorexia, losses of
lean tissue and body fat, and the hepatic acute phase response in patients
or experimental animals with cancer can be attributed in part to an
inappropriate or excessive production of cytokines, including interleukin-1
alpha or beta (IL-1), tumor necrosis factor-alpha (TNF-alpha/cachectin)
and/or interleukin-6 (interferon-beta2). Experimental evidence suggests
that either the tumor itself or tumor-infiltrating macrophages and other
accessory cells, blood monocytes, or macrophages contained in organs of the
reticuloendothelial system may be spontaneously releasing one or more of
these cytokines. Therefore, in this application, cytokine production (IL-
1. TNF-alpha and IL-6) will be evaluated directly in the tumors of
cachectic mice and of weight-losing patients by measuring both the quantity
of cytokine-specific mRNA and immune reactive protein present, and from
organs of the reticuloendothelial system of tumor-bearing mice. In
addition, to determine whether the production of one or more of these
cytokines is contributing directly to the development of cancer cachexia,
specific neutralizing polyclonal and monoclonal antibodies directed against
these cytokines and/or their tissue receptors will be administered in vivo
to tumor-bearing mice in order to determine whether blocking the actions of
these cytokines can either reduce the severity of or prevent the
development of cancer cachexia. Thus, the specific goal of this
application is to determine whether tumor specific or associated cytokine
production are common findings in experimental and human cancer, whether
the cytokines are of tumor or host origin, and finally, whether the host
changes in food intake, carcass protein and fat composition, and hepatic
acute phase response can be attributed to the inappropriate production of
these cytokines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
-
批准号:10439853
-
项目类别:
-
资助金额:$74.89万
-
财政年份:2020
-
负责人:LYLE L MOLDAWER
-
依托单位:
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
-
批准号:10651650
-
项目类别:
-
资助金额:$73.48万
-
财政年份:2020
-
负责人:LYLE L MOLDAWER
-
依托单位:
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
-
批准号:10042541
-
项目类别:
-
资助金额:$80.15万
-
财政年份:2020
-
负责人:LYLE L MOLDAWER
-
依托单位:
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
-
批准号:10254395
-
项目类别:
-
资助金额:$76.16万
-
财政年份:2020
-
负责人:LYLE L MOLDAWER
-
依托单位:
Administrative Supplement: Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
-
批准号:10683437
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2020
-
负责人:LYLE L MOLDAWER
-
依托单位:
Validation of a Genomics Based Prognostic in Severe Trauma
-
批准号:8668117
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2013
-
负责人:LYLE L MOLDAWER
-
依托单位:
Validation of a Genomics Based Prognostic in Severe Trauma
-
批准号:9061719
-
项目类别:
-
资助金额:$44.93万
-
财政年份:2013
-
负责人:LYLE L MOLDAWER
-
依托单位:
Validation of a Genomics Based Prognostic in Severe Trauma
-
批准号:8427852
-
项目类别:
-
资助金额:$46.58万
-
财政年份:2013
-
负责人:LYLE L MOLDAWER
-
依托单位:
Inflammation and Repair as Determinants of Hemodialysis Fistula Maturation
-
批准号:8450880
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Inflammation and Repair as Determinants of Hemodialysis Fistula Maturation
-
批准号:8093245
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Inflammation and Repair as Determinants of Hemodialysis Fistula Maturation
-
批准号:8249824
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Inflammation and Repair as Determinants of Hemodialysis Fistula Maturation
-
批准号:8636463
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
-
批准号:8611931
-
项目类别:
-
资助金额:$27.84万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
-
批准号:8244431
-
项目类别:
-
资助金额:$27.84万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
-
批准号:8093830
-
项目类别:
-
资助金额:$27.84万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
-
批准号:8410095
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2011
-
负责人:LYLE L MOLDAWER
-
依托单位:
Cytokine Regulation in Sepsis/Inflammation
-
批准号:7915851
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2009
-
负责人:LYLE L MOLDAWER
-
依托单位:
Myeloid Suppressor Cells in Sepsis and Trauma
-
批准号:7771716
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2008
-
负责人:LYLE L MOLDAWER
-
依托单位:
Myeloid Suppressor Cells in Sepsis and Trauma
-
批准号:8652469
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2008
-
负责人:LYLE L MOLDAWER
-
依托单位:
Myeloid Suppressor Cells in Sepsis and Trauma
-
批准号:8037086
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2008
-
负责人:LYLE L MOLDAWER
-
依托单位:
海外基金